This company seems to have been delisted
Reason: Filed for chapter 7 bankruptcy
Last recorded trade on: December 27, 2023
Source: https://www.genomeweb.com/business-news/biocept-files-chapter-7-bankruptcy
Reason: Filed for chapter 7 bankruptcy
Last recorded trade on: December 27, 2023
Source: https://www.genomeweb.com/business-news/biocept-files-chapter-7-bankruptcy
Biocept
BIOC
$0.62
Share price
0.00%
Change (1 day)
-95.53%
Change (1 year)
Categories
EPS for Biocept (BIOC)
EPS in 2023 (TTM): -$69.09
According to Biocept 's latest financial reports the company's current EPS (TTM) is -$72.52. In 2022 the company made an earnings per share (EPS) of -$80.95 a decrease over its 2021 EPS that were of -$7.27.
EPS history for Biocept from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$69.09 | -14.66% |
| 2022 | -$80.95 | 1014.12% |
| 2021 | -$7.27 | -90.56% |
| 2020 | -$76.94 | -87.47% |
| 2019 | -$614.21 | -85.46% |
| 2018 | -$4,223 | -58.7% |
| 2017 | -$10,224 | -62.38% |
| 2016 | -$27,176 | -21.83% |
| 2015 | -$34,766 | -74.78% |
| 2014 | -$137,837 | 74.98% |
| 2013 | -$78,773 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | -$2.26 | -96.88% | 🇺🇸 USA |
 | -$4.33 | -94.03% | 🇺🇸 USA |
 | -$0.57 | -99.21% | 🇺🇸 USA |